Imaflex Stock Fundamentals

IFX Stock  CAD 1.47  0.02  1.38%   
Imaflex fundamentals help investors to digest information that contributes to Imaflex's financial success or failures. It also enables traders to predict the movement of Imaflex Stock. The fundamental analysis module provides a way to measure Imaflex's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imaflex stock.
At this time, Imaflex's Interest Expense is fairly stable compared to the past year. Operating Income is likely to climb to about 3.1 M in 2024, whereas Total Revenue is likely to drop slightly above 62.7 M in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Imaflex Company Profit Margin Analysis

Imaflex's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Imaflex Profit Margin

    
  0.04 %  
Most of Imaflex's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imaflex is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Imaflex Profit Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Imaflex is extremely important. It helps to project a fair market value of Imaflex Stock properly, considering its historical fundamentals such as Profit Margin. Since Imaflex's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Imaflex's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Imaflex's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Imaflex Pretax Profit Margin

Pretax Profit Margin

0.008256

At this time, Imaflex's Pretax Profit Margin is fairly stable compared to the past year.
Based on the latest financial disclosure, Imaflex has a Profit Margin of 0.0434%. This is 98.28% lower than that of the Containers & Packaging sector and 102.23% lower than that of the Materials industry. The profit margin for all Canada stocks is 103.42% lower than that of the firm.

Imaflex Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Imaflex's current stock value. Our valuation model uses many indicators to compare Imaflex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Imaflex competition to find correlations between indicators driving Imaflex's intrinsic value. More Info.
Imaflex is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers reporting about  0.68  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Imaflex is roughly  1.47 . At this time, Imaflex's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imaflex's earnings, one of the primary drivers of an investment's value.

Imaflex Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imaflex's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Imaflex could also be used in its relative valuation, which is a method of valuing Imaflex by comparing valuation metrics of similar companies.
Imaflex is currently under evaluation in profit margin category among its peers.

Imaflex Current Valuation Drivers

We derive many important indicators used in calculating different scores of Imaflex from analyzing Imaflex's financial statements. These drivers represent accounts that assess Imaflex's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Imaflex's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap32.5M52.0M61.3M79.1M46.2M48.5M
Enterprise Value48.9M58.6M62.4M79.6M56.8M59.6M

Imaflex Fundamentals

About Imaflex Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Imaflex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imaflex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imaflex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.7 M900 K
Total Revenue93.6 M62.7 M
Cost Of Revenue82.8 M53.8 M
Sales General And Administrative To Revenue 0.07  0.07 
Capex To Revenue 0.14  0.15 
Revenue Per Share 1.80  1.06 
Ebit Per Revenue 0.03  0.05 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imaflex Stock Analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.